Share

Profile & Fundamentals

Teladoc Health Profile & Fundamentals

Name: Teladoc Health financial chart data preview
Creator: iPulse AI
License: https://ipulseai.com/terms

Examine company identity, ownership, reported performance, valuation, balance-sheet resilience, dividends, buybacks, and material corporate events.

Interactive annual & quarterly chartsAI financial reviewsReported source tables

Explore this pageJump to a Profile & Fundamentals section

Explore this research

Profile & Fundamentals contents

Jump directly to any section

Company and Market Context

Company Profile & Ownership

Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through websites, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc and BetterHelp brands. It serves employers, health plans, hospitals and health systems, insurance companies, and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in New York, New York.

Company profile record

Teladoc Inc

Common Stock · Health Care · Health Care Technology

Official website

Company

Company / asset: Teladoc Inc
Security type: Common Stock
Sector: Health Care
Industry: Health Care Technology
HQ: 🇺🇸 United States
Head office: 155 E 44th Street, New York, NY, United States, 10017

Leadership & scale

Chief executive: Mr. Charles Divita III, C.P.A.
CEO year born: 1970
Full-time employees: 4.6K
Fiscal year end: December
IPO date: 2015-07-01

Fundamentals snapshot

Updated 2026-09-16

Market Cap: USD 1.1B
P/E: --
Revenue (Q2 26): USD 606.9M
Profit (Q2 26): USD -38.9M
Dividend Yield: --
Revenue (FY 25): USD 2.5B
Shares in public float: 180.4M
Insider ownership: 0.72%

Reporting & identifiers

Symbol: TDOC.NYSE
Listing: 🇺🇸 United States | Dividend Tax: 30%
Ticker Currency: USD
Income Statement Currency: USD
Balance Sheet Currency: USD
Cash Flow Currency: USD
EPS Currency: USD
Contract Type: SPOT
ISIN: US8785296071
Asset ID: equity_278e7a41-fd2f-5ab1-9536-f91c9f1c1b68

Ownership

Shares Outstanding

Shares outstanding

Annual reported shares outstanding. Values in shares.

Top holders

BlackRock Inc14,613,556 shares · 8.04% · Reported 2026-03-31
Vanguard Portfolio Management, LLC12,295,094 shares · 6.77% · Reported 2026-03-31
Renaissance Technologies Corp8,085,542 shares · 4.45% · Reported 2026-03-31
Voss Capital LLC8,046,679 shares · 4.43% · Reported 2026-06-30
Vanguard Capital Management, LLC7,857,169 shares · 4.32% · Reported 2026-03-31
Point72 Asset Management, L.P.7,721,495 shares · 4.25% · Reported 2026-03-31
Dimensional Fund Advisors, Inc.7,371,699 shares · 4.06% · Reported 2026-06-30

View more holders (8)

Avantis US Small Cap Value ETF7,044,610 shares · 3.88% · Reported 2026-08-31
Vanguard MStar Total Stk Mkt Idx Invest5,741,272 shares · 3.16% · Reported 2026-07-31
American Century Companies Inc4,894,504 shares · 2.69% · Reported 2026-06-30
iShares Russell 2000 ETF4,691,987 shares · 2.58% · Reported 2026-08-31
Allianz Asset Management AG4,666,596 shares · 2.57% · Reported 2026-06-30
State Street Corp4,359,751 shares · 2.40% · Reported 2026-03-31
Geode Capital Management, LLC4,180,484 shares · 2.30% · Reported 2026-03-31
Vanguard Small Cap Index4,155,204 shares · 2.29% · Reported 2026-07-31

Earnings, Profitability & Valuation

Earnings & Revenue

AI Review

The company is experiencing a clear split between its sales performance and its actual cash generation. On one hand, overall revenue is slightly shrinking as the post-pandemic boom fades and the company intentionally cuts back on expensive marketing for its therapy business. This decline makes the company look unhealthy on paper to casual observers. On the other hand, the business is highly successful at converting its remaining sales into real cash, bringing in over two hundred fifty million dollars in free cash flow. While some experts worry that shrinking sales will eventually drag down cash flow, others believe that cutting unprofitable services and focusing on steady insurance contracts will stabilize the business. The consensus is that the cash flow is highly durable, but opinions differ on whether the company can ever return to true sales growth.

Revenue, Net Income, and Free Cash Flow

Revenue
Free cash flow
Net income

Annual reported financial results, converted using the statement's recorded USD conversion. Missing values are omitted. Values in USD.

Valuation

Historical P/E Ratio

The published data is insufficient to draw this chart.

Profitability & Margins

AI Review

The company's profit margins present a tale of two realities. The basic cost of delivering its service is very low, allowing it to maintain excellent gross margins of around seventy percent. However, heavy spending on administration, marketing, and past acquisition write-downs has kept its final net profits in negative territory. There is a clear clash over where these margins are headed. Some believe that using smart software to automate paperwork and shifting the therapy business to insurance will dramatically lower overhead costs, causing final profits to jump. Others argue that intense competition will force the company to lower its prices, wiping out any savings from cost-cutting. While everyone agrees the core service is highly profitable, the debate continues over whether management can successfully trim the fat to reveal those profits to shareholders.

Profitability Margins

Gross margin
Operating margin
Net margin
Free cash flow margin

Annual gross, operating, net income and free cash flow divided by revenue for matching reporting dates. Values in percent.

Complete Research Workspace

Unlock the complete Profile & Fundamentals

Sign in to verify your access, or upgrade to the Base plan to open the complete profile & fundamentals and available source data.

Sign in to check access View Base plan

Paywalled preview begins: Reported Data Tables — chart preview

From this section to the end-of-preview notice below, research is provided as simplified HTML text and tables. Full access provides the complete interactive interface, charts and additional datasets.

Reported Data Tables — chart preview

The following tables contain the same values as the financial charts above. Monetary values are USD; margins are percentages. Missing inputs are not estimated. Use is subject to the iPulse AI Terms of Service and applicable source rights.

Source: eodhd. Statement snapshots with chart transformations and ratios calculated by iPulse AI. Snapshot retrieved 2026-09-17.

Annual earnings and profitability
Period end	Revenue	Free cash flow	Net income	Gross margin	Operating margin	Net margin	Free cash flow margin
2016-12-31	123,157,000	-55,207,000	-74,216,000	74.04	-50.88	-60.26	-44.83
2017-12-31	233,279,000	-39,956,000	-106,782,000	73.58	-32.32	-45.77	-17.13
2018-12-31	417,907,000	-13,267,000	-97,084,000	69.2	-16.95	-23.23	-3.17
2019-12-31	553,307,000	18,969,000	-98,864,000	66.66	-14.54	-17.87	3.43
2020-12-31	1,093,962,000	-79,553,000	-485,136,000	64.27	-46.29	-44.35	-7.27
2021-12-31	2,032,707,000	185,456,000	-428,793,000	68.01	-13.07	-21.09	9.12
2022-12-31	2,406,840,000	172,812,000	-13,659,531,000	69.09	-548.37	-567.53	7.18
2023-12-31	2,602,415,000	193,673,000	-220,368,000	70.8	-9.55	-8.47	7.44
2024-12-31	2,569,574,000	282,890,000	-1,001,245,000	70.76	-39.73	-38.97	11.01
2025-12-31	2,529,977,000	285,464,000	-200,322,000	69.5	-10.39	-7.92	11.28

Shares outstanding — chart values
Reporting date	Shares outstanding
2017-01-01	58,371,500
2018-01-01	70,239,500
2019-01-01	72,564,900
2020-01-01	128,298,000
2021-01-01	159,944,300
2022-01-01	162,169,600
2023-01-01	166,059,000
2024-01-01	172,765,000
2025-01-01	176,221,500
2026-01-01	180,079,400

End of the paywalled preview

The excerpt from Reported Data Tables — chart preview to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.

Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.

Additional with full access

Earnings, Profitability & Valuation
- Complete profitability ratios
- EPS history and estimate comparisons
- Execution vs expectations
- Annual and quarterly financial views
Capital Expenditure & R&D
- Capital allocation AI review
- Annual capital expenditure
- Investment intensity trends
- Capex and R&D intensity indicators
Balance Sheet
- Balance sheet AI review
- Assets, debt and equity
- Capital structure
- Liquidity and leverage
- Retained earnings
Dividends & Actions
- Cash dividends paid
- Dividend indicators
- Buybacks and issuance
- Combined shareholder returns
- Available corporate actions
Company Events
- Dated insider transactions
- Material company activity

Explore complete public research examples

These public assets show the complete asset profiles, fundamental datasets and analysis. Their findings concern those assets, not this report.